VALENCIA, Sepanyol, June 03, 2024 (GLOBE NEWSWIRE) — Kongres Antarabangsa EAACI telah bermula dengan slogan “Merevolusikan penjagaan pesakit melalui kuasa sains data.” Dalam masa empat hari akan datang, pakar-pakar akan

DUBAI, United Arab Emirates, June 02, 2024 (GLOBE NEWSWIRE) — OKX, a leading crypto exchange and Web3 technology company, has issued updates for June 2, 2024. OKX Now Supports Wormhole

JEDDAH, Saudi Arabia, June 02, 2024 (GLOBE NEWSWIRE) — In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) — COMPUTEX — To address the increasing need for real-time AI computing at the industrial edge, NVIDIA today announced the general software availability of NVIDIA

VANCOUVER, British Columbia, May 31, 2024 (GLOBE NEWSWIRE) — Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., “Metasphere Labs” or the “Company“) (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is

Austin, Texas, June 02, 2024 (GLOBE NEWSWIRE) — ePac Flexible Packaging, founded in 2016 as the world’s first all-digital flexible packaging company, just turned 8 years old in May of

Investigational chemotherapy-free regimen of amivantamab plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk disease1 Landmark Phase 3 MARIPOSA data featured in an oral

26% reduction in risk of death (HR=0.74) and 28% risk reduction in progression or death (HR=0.72) in previously-treated patients administered with CM24+nivolumab+Nal/IRI/5FU/LV vs. standard-of-care(SoC) based on preliminary interim data Prolongation

SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain

An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacy SYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in

Initial data from the ongoing Phase 2 trial showed a 12-month overall survival rate of 69% and a median overall survival of 17.5 months in patients with previously treated PD-L1-positive

NASSAU, The Bahamas, June 01, 2024 (GLOBE NEWSWIRE) — OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for June 1, 2024.

GUANGZHOU, China, June 01, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced

Luxembourg – 1 June 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced, after a competitive tender process, the award by Petrobras of four long-term day-rate contracts for pipelay support

DUBAI, United Arab Emirates, June 01, 2024 (GLOBE NEWSWIRE) — OKX, a leading crypto exchange and Web3 technology company, has issued updates for June 1, 2024. OKX Lists WLD/USDC Spot